SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris

MLA

Claudio Fenizia, et al. “SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris.” Journal of Investigative Dermatology, Jan. 2023. EBSCOhost, https://doi.org/10.1016/j.jid.2022.12.023.

APA

Claudio Fenizia, Chiara Moltrasio, Luisa Ottobrini, Olga Utyro, Giovanni Genovese, Claudia Vanetti, Daria Trabattoni, & Angelo V. Marzano. (2023). SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2022.12.023

Chicago

Claudio Fenizia, Chiara Moltrasio, Luisa Ottobrini, Olga Utyro, Giovanni Genovese, Claudia Vanetti, Daria Trabattoni, and Angelo V. Marzano. 2023. “SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris.” Journal of Investigative Dermatology, January. doi:10.1016/j.jid.2022.12.023.